Jiaojiao L. Hou

Shijiazhuang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Bladder metastasis from gastric cancer presenting as acute post-renal obstruction during immunotherapy: a case report.

Bladder metastasis from gastric cancer presenting as acute post-renal obstruction during immunotherapy: a case report.

Journal: Frontiers in oncology

Published: April 06, 2026

Treatment strategies for small cell carcinoma of the esophagus: comparative analysis of multimodal regimens in two independent real-world cohorts.

Treatment strategies for small cell carcinoma of the esophagus: comparative analysis of multimodal regimens in two independent real-world cohorts.

Journal: The oncologist

Published: October 15, 2025

Single-cell transcriptomic analysis reveals epithelial and microenvironmental heterogeneity in small cell carcinoma of the esophagus.

Single-cell transcriptomic analysis reveals epithelial and microenvironmental heterogeneity in small cell carcinoma of the esophagus.

Journal: Frontiers in immunology

Published: July 24, 2025

Visualized Clinical-Radiomics Model Based on Non-Contrast Computed Tomography for Predicting Efficacy of Surufatinib in Hepatic Metastases of Neuroendocrine Neoplasms.

Visualized Clinical-Radiomics Model Based on Non-Contrast Computed Tomography for Predicting Efficacy of Surufatinib in Hepatic Metastases of Neuroendocrine Neoplasms.

Journal: Cancer medicine

Published: July 18, 2025

TOP2A as a prognostic biomarker in small cell carcinoma of the esophagus: an integrated bioinformatics and immunohistochemical study.

TOP2A as a prognostic biomarker in small cell carcinoma of the esophagus: an integrated bioinformatics and immunohistochemical study.

Journal: Frontiers in molecular biosciences

Published: June 04, 2025

Visualized clinical-radiomics model for predicting the efficacy of surufatinib in hepatic metastases of neuroendocrine neoplasms.

Visualized clinical-radiomics model for predicting the efficacy of surufatinib in hepatic metastases of neuroendocrine neoplasms.

Journal: Frontiers in oncology

Published: May 13, 2025

Single-cell transcriptomic analysis reveals a metastasis-associated PCSK1+ neuroendocrine subpopulation in pancreatic neuroendocrine tumors.

Single-cell transcriptomic analysis reveals a metastasis-associated PCSK1+ neuroendocrine subpopulation in pancreatic neuroendocrine tumors.

Journal: Journal of neuroendocrinology

Published: April 15, 2025

Identification and validation of a lenvatinib resistance-related prognostic signature in HCC, in which PFKFB4 contributes to tumor progression and lenvatinib resistance.

Identification and validation of a lenvatinib resistance-related prognostic signature in HCC, in which PFKFB4 contributes to tumor progression and lenvatinib resistance.

Journal: BMC gastroenterology

Published: December 18, 2024

Development and validation of a prognostic model for overall survival in small cell carcinoma of the esophagus.

Development and validation of a prognostic model for overall survival in small cell carcinoma of the esophagus.

Journal: Frontiers in oncology

Published: December 13, 2024

A Comparative Study on the Progression of Neuroendocrine Carcinomas and Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms.

A Comparative Study on the Progression of Neuroendocrine Carcinomas and Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms.

Journal: Oncology

Published: August 23, 2024

Genome-wide association study for high-temperature tolerance in the Japanese flounder.

Genome-wide association study for high-temperature tolerance in the Japanese flounder.

Journal: Animal : an international journal of animal bioscience

Published: April 24, 2024

Transarterial Chemoembolization Combined With PD-1 Inhibitors Plus Lenvatinib Showed Improved Efficacy for Treatment of Unresectable Hepatocellular Carcinoma Compared With PD-1 Inhibitors Plus Lenvatinib.

Transarterial Chemoembolization Combined With PD-1 Inhibitors Plus Lenvatinib Showed Improved Efficacy for Treatment of Unresectable Hepatocellular Carcinoma Compared With PD-1 Inhibitors Plus Lenvatinib.

Journal: Technology in cancer research & treatment

Published: May 10, 2023

Showing 1-12 of 14

Last Updated: 09/26/2026